# Median Effective Dose of Remimazolam for Sedation in Elderly Patients

> **NCT05468996** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Sedative

## Interventions

- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT05468996
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-10
- **Primary completion:** 2022-10-28
- **Final completion:** 2022-10-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05468996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05468996, "Median Effective Dose of Remimazolam for Sedation in Elderly Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05468996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*